Relay Therapeutics’ (RLAY) “Buy” Rating Reaffirmed at HC Wainwright
Relay Therapeutics (NASDAQ:RLAY – Get Free Report)‘s stock had its “buy” rating restated by equities research analysts at HC Wainwright in a note issued to investors on Friday,Benzinga reports. They presently have a $16.00 price target on the stock. HC Wainwright’s target price indicates a potential upside of 362.43% from the stock’s current price. Several […]
Relay Therapeutics (NASDAQ:RLAY – Get Free Report)‘s stock had its “buy” rating restated by equities research analysts at HC Wainwright in a note issued to investors on Friday,Benzinga reports. They presently have a $16.00 price target on the stock. HC Wainwright’s target price indicates a potential upside of 362.43% from the stock’s current price. Several […]
